Previous Article | Next Article ![]()
Mol. Cell. Biol., 08 1997, 4249-4258, Vol 17, No. 8
S Bontron, C Ucla, B Mach and V Steimle
Major histocompatibility complex class II (MHC-II) molecules present
peptide antigens to CD4-positive T cells and are of critical importance for
the immune response. The MHC-II transactivator CIITA is essential for all
aspects of MHC-II gene expression examined so far and thus constitutes a
master regulator of MHC-II expression. In this study, we generated and
analyzed mutant CIITA molecules which are able to suppress endogenous
MHC-II expression in a dominant negative manner for both constitutive and
inducible MHC-II expression. Dominant negative CIITA mutants were generated
via specific restriction sites and by functional selection from a library
of random N-terminal CIITA deletions. This functional selection strategy
was very effective, leading to strong dominant negative CIITA mutants in
which the N- terminal acidic and proline/serine/threonine-rich regions were
completely deleted. Dominant negative activity is dependent on an intact C
terminus. Efficient repression of endogenous MHC-II mRNA levels was
quantified by RNase protection analysis. The quantitative effects of
various dominant negative CIITA mutants on mRNA expression levels of the
different MHC-II isotypes are very similar. The optimized dominant negative
CIITA mutants isolated by functional selection should be useful for in vivo
repression of MHC-II expression.
Copyright © 1997, American Society for Microbiology
Efficient repression of endogenous major histocompatibility complex class II expression through dominant negative CIITA mutants isolated by a functional selection strategy
Department of Genetics and Microbiology, University of Geneva Medical School, Switzerland.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»